注ï¼ãã®è¨äºã¯ãæèè å人ã®æè¦ã§ããæ¥æ¬å»å¸«ä¼ã¾ãã¯æ¥æ¬å»å¸«ä¼COVID-19æèè ä¼è°ã®è¦è§£ã§ã¯ãªããã¨ã«çæãã ããã æ°åã³ããã¦ã¤ã«ã¹ææç(COVID-19)ã¯ãSARS-CoV-2ã¦ã¤ã«ã¹ã«ããå¼ãèµ·ããããææçã§ããã ç´80ï¼ ã®ææè ã¯ç¡çç¶ã軽çã§çµéããããç´20ï¼ ã¯éçèºçã¨ãªãããã®ãã¡30%ã¯è´æ»çãªæ¥æ§å¼å¸ä¿è¿«çå群(ARDS)ã¨ãªãã ç¾æç¹ã§æå¹ãªæã¦ã¤ã«ã¹è¬ããARDSã«å¯¾ãã確ç«ããæ²»çæ¹æ³ã¯ãªãã1æ¥ãæ©ãæ²»çè¬ã®éçºãæã¾ããã SARS-CoV-2ã¯ACE2ãå容ä½ã¨ãã¦ææããèªç¶å ç«ç³»ã¨AngII-AT1Rãä»ãã¦ãNF-kBã¨SATA3転åå åã®æ´»æ§åãèªå°ãããSTAT3ã¯NF-kBã®æ´»æ§åãå¢å¼·ãããã¨ã«ãããIL-6ãªã©ã®ççæ§ãµã¤ãã«ã¤ã³ç£çãå¢å¼·ããã ãã®å¢å¹ åè·¯ã¯IL-6ã¢ã³ãã¨å¼ç§°ããããé¢ç¯ãªã¦ãããªã©ã®æ ¢æ§ççæ§ç¾æ£çº
{{#tags}}- {{label}}
{{/tags}}